Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesPrenetics Global Ltd

Prenetics Global Ltd

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
15.94 USD -0.18 ( 1.12%)
Last update at 2026-11-06T21:00:00Z
VOLUME
100707
Market Cap
74.77M

Momentum Score

…

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
15.21
Low
16.38
High
52 Week Price Range
2.85
Low
15.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Prenetics Global Ltd is a molecular diagnostics company offering consumer and clinical genetic testing and laboratory services across multiple markets. Long-term growth may be supported by rising adoption of genomics in personalized medicine, expansion of clinical diagnostics and scaling of lab capacity in APAC and beyond. Investors may find it attractive because the business appears positioned to benefit from growing demand for diagnostics and personalized health services.
Key risks include regulatory and reimbursement uncertainty, intense competition in diagnostics, and execution and profitability pressures as the company scales.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
16.12
Dividend Yield
-
Revenue TTM
21.74M
Revenue Per Share
1.93
Gross Profit TTM
131.55M
Debt / Equity
0.01
ROE
-24.87%
Net Debt
-43.34M
ROCE
96.61%
Diluted EPS TTM
-4.83

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2015-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2015-12-31
Income before tax -183.31M -170.28M -3.90M -20.87M 180.44M
Minority interest 0.00M 0.01M 0.02M 0.05M 2.77M
Net income -190.45M -174.02M -1.96M -20.20M 104.38M
Selling general administrative 96.06M 83.99M 16.62M 13.19M -
Selling and marketing expenses 13.30M 21.93M 6.49M 4.77M -
Gross profit 131.55M 106.13M 26.34M 2.72M 668.70M
Reconciled depreciation 7.54M 7.35M 2.43M 2.23M -
Ebit 207.42M -10.35M 0.97M -18.23M -
Ebitda 43.22M -162.44M -0.56M -18.52M -
Depreciation and amortization -164.20M -152.09M -1.53M -0.29M -
Operating income 207.42M -10.35M 0.97M -18.23M 642.11M
Other operating expenses 269.09M 286.20M 64.21M 27.46M -
Interest expense 4.20M 0.23M 0.06M 0.07M 0.00M
Tax provision 7.15M 3.73M -1.94M -0.68M -
Interest income 0.47M 0.00M 0.01M 0.02M -
Net interest income -4.20M -5.23M -0.05M -0.05M -
Income tax expense 7.15M 3.73M -1.94M -0.68M 79.66M
Total revenue 275.76M 275.85M 65.18M 9.23M 5477.06M
Total operating expenses 124.88M 116.48M 25.38M 20.94M -
Cost of revenue 144.21M 169.72M 38.83M 6.52M 4761.92M
Total other income expense net -390.72M -159.94M -4.87M -2.64M -
Net income from continuing ops -190.45M -174.02M -1.96M -20.20M -
Net income applicable to common shares -190.45M -174.01M -1.94M -20.14M 47.65M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 254.17M 307.98M 148.51M 78.88M -
Intangible assets 13.42M 11.28M 23.83M 24.10M -
Other current assets 4.32M 24.50M 7.41M 0.89M -
Total liab 44.01M 67.94M 549.40M 47.88M -
Total stockholder equity 206.36M 237.06M -400.81M 31.08M -
Deferred long term liab - 6.31M 2.16M 0.13M -
Other current liab 30.20M 41.35M 37.50M 25.71M 7.79M
Common stock 0.02M 0.01M 0.00M 53.24M 45.69M
Capital stock 0.02M 0.01M 0.00M 53.24M -
Retained earnings -470.77M - -217.59M -43.58M -41.64M
Other liab - 6.98M 0.66M - 0.03M
Good will 29.17M 32.83M 3.98M 3.99M -
Other assets - 7.84M 2.94M 2.28M 0.16M
Cash 45.71M 146.66M 35.29M 14.49M -
Total current liabilities 39.48M 57.20M 58.74M 47.07M 11.90M
Current deferred revenue 6.11M 5.67M 9.59M 7.05M -
Net debt -43.34M -140.01M -30.02M -12.82M -
Short term debt 1.50M 2.88M 1.67M 0.87M -
Short long term debt total 2.37M 6.65M 5.27M 1.67M -
Other stockholder equity 853.16M 237.05M -200.35M 21.42M 12.86M
Property plant equipment - 13.10M 13.04M 4.69M 2.11M
Total current assets 85.35M 242.14M 106.89M 43.96M 15.63M
Long term investments 107.84M 0.79M 0.00M 0.00M -
Net tangible assets - 192.96M -426.45M -34.76M 6.78M
Short term investments 27.03M 17.54M 9.91M 0.00M -
Net receivables 5.16M 48.58M 47.46M 24.08M 3.27M
Inventory 3.13M 4.86M 6.83M 4.50M 0.55M
Accounts payable 1.67M 7.29M 9.98M 13.44M 2.76M
Accumulated other comprehensive income -646.80M 237.05M -400.81M -22.16M -
Non currrent assets other 12.59M 7.60M 0.69M 0.19M -
Non current assets total 168.82M 65.84M 41.61M 34.93M -
Capital lease obligations 2.37M 6.65M 5.27M 1.67M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2015-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2015-12-31
Investments -46.14M -22.02M -5.97M -4.60M -
Change to liabilities 0.00M -0.92M 11.19M 5.53M -
Total cashflows from investing activities - -22.02M -5.97M -4.60M 295.27M
Net borrowings - 3.55M 11.89M -0.50M -
Total cash from financing activities 143.32M 29.32M 11.84M -0.57M -
Change to operating activities - 20.72M 4.85M 2.43M -
Net income -190.45M -174.02M -1.96M -20.20M 104.38M
Change in cash 111.37M 20.80M 2.97M -7.26M -
Begin period cash flow 35.29M 14.49M 11.52M 18.78M -
End period cash flow 146.66M 35.29M 14.49M 11.52M 18.78M
Total cash from operating activities 14.51M 13.42M -2.88M -1.88M 318.81M
Issuance of capital stock 0.12M 25.97M 0.00M 0.00M -
Depreciation 7.54M 7.35M 2.43M 2.23M -
Other cashflows from investing activities - 0.00M 0.00M 0.01M -
Dividends paid 0.00M 0.00M 0.00M 0.00M 190.34M
Change to inventory 1.26M -2.33M -3.75M 0.42M -
Change to account receivables 6.97M -24.05M -20.09M 1.83M -
Sale purchase of stock -0.66M - 0.00M - -
Other cashflows from financing activities 145.74M 30.62M 12.45M -0.07M -
Change to netincome - 186.67M 4.42M 5.82M -
Capital expenditures 6.34M 11.41M 3.06M 0.37M 0.00M
Change in working capital -33.76M -6.59M -7.79M 10.21M -
Stock based compensation 31.58M 22.49M 1.62M 3.91M -
Other non cash items 192.46M 160.45M 4.77M 2.64M -
Free cash flow 8.17M 2.00M -5.94M -2.26M -

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PRE
Prenetics Global Ltd		 -0.18
1.12%		 15.94 - - 2.09 0.20 0.02 1.51
TMO
Thermo Fisher Scientific Inc		 17.82
2.63%		 694.76 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 3.91
1.73%		 230.25 29.09 28.01 5.67 3.20 6.00 19.09
WUXIF
WuXi AppTec Co. Ltd		 -
-%		 25.45 22.29 17.95 1.53 5.98 8.39 14.30
WUXAY
WuXi AppTec Co. Ltd		 -0.31
1.23%		 24.85 23.28 18.73 1.51 6.24 8.39 14.30

Profile*

Prenetics Global Ltd

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

Unit 701-706, Quarry Bay, Hong Kong

852 2210 9588

https://www.prenetics.com

320

Name Title Year Born
Mr. Sheng Wu Yeung Co-Founder, Chairperson & CEO 1979
Dr. Chi Hung Tzang Ph.D. Co-Founder, Chief Scientific Officer & Member of Scientific Advisory Board 1975
Mr. Hoi Chun Lo Chief Financial Officer 1985
Dr. Yung Ho Wong DPHIL Chief Technology Officer 1982
Ms. Samantha Kwok Chief of Staff to Group CEO & Vice President, People & Operations NA
Dr. Senthil Sundaram M.D. Chief Clinical Officer 1974
Mr. Joel Neoh Chief Consumer Officer & Chief Executive Officer for CircleDNA NA
Mr. Walt Ling Chief Executive Officer of ACT Genomics NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…